February 1, 2018 / 9:35 PM / 19 days ago

BRIEF-Allergan Says FDA Approves Avycaz For Treating Patients With HABP/VABP

Feb 1 (Reuters) - Allergan Plc:

* ALLERGAN - FDA APPROVES AVYCAZ (CEFTAZIDIME & AVIBACTAM) FOR TREATING PATIENTS WITH HOSPITAL-ACQUIRED & VENTILATOR-ASSOCIATED BACTERIAL PNEUMONIA

* ALLERGAN - EXPANDED USE BASED ON RESULTS FROM PHASE 3 STUDY EVALUATING EFFICACY, SAFETY OF AVYCAZ FOR TREATING ADULT PATIENTS WITH HABP/VABP Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below